. 2025 Mar 21;33(4):311. doi: 10.1007/s00520-025-09362-4

Table 2.

Association between AL and development of lymphedema (n = 3,609)*

Crude OR (95% CI)

Adjusted OR (95% CI)

AL (continuous)

1-unit increase

1.10 (1.05–1.16)

1.10 (1.04–1.16)

AL (in quartiles)

Q1 (0–1)

Q2 (2)

Q3 (3–4)

Q4 (5 +)

Ref

1.11 (0.87–1.43)

1.31 (1.05–1.64)

1.55 (1.16–2.06)

Ref

1.09 (0.84–1.43)

1.28 (1.00–1.64)

1.51 (1.09–2.08)

AL (binary)

Low (≤ 2)

High (> 2)

Ref

1.31 (1.10–1.56)

Ref

1.28 (1.06–1.55)

^*Adjusted for age, race, chemotherapy, radiation therapy, breast surgery type, and lymph node surgery type